Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson’s Disease

Existing therapies for Parkinson’s disease (PD) are only symptomatic. As erythropoietin (EPO) is emerging for its benefits in neurodegenerative diseases, here, we test the protective effect driven by EPO in in vitro (SH-SY5Y cells challenged by MPP(+)) and in vivo (C57BL/6J mice administered with MP...

詳細記述

保存先:
書誌詳細
出版年:Antioxidants (Basel)
主要な著者: Rey, Federica, Ottolenghi, Sara, Giallongo, Toniella, Balsari, Alice, Martinelli, Carla, Rey, Robert, Allevi, Raffaele, Giulio, Anna Maria Di, Zuccotti, Gian Vincenzo, Mazzucchelli, Serena, Foresti, Roberta, Samaja, Michele, Carelli, Stephana
フォーマット: Artigo
言語:Inglês
出版事項: MDPI 2021
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7830512/
https://ncbi.nlm.nih.gov/pubmed/33467745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antiox10010121
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料